Olema Pharmaceuticals, Inc.
OLMA
$10.63
$0.121.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.05% | -15.26% | -9.11% | 3.58% | -44.08% |
| Total Depreciation and Amortization | -14.29% | -36.36% | 334.88% | -67.42% | 3.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.58% | 169.09% | 5.61% | -1.16% | 27.42% |
| Change in Net Operating Assets | 338.03% | -153.01% | -6.36% | -57.93% | 164.50% |
| Cash from Operations | 0.20% | -19.99% | -11.01% | -15.54% | 32.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 806.65% | 102.79% | -1,038.95% | -49.54% | 175.94% |
| Cash from Investing | 801.77% | 102.79% | -1,038.95% | -49.54% | 175.94% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.25% | -77.78% | 552,734.15% | -95.82% | 316.10% |
| Repurchase of Common Stock | 19.74% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 190.46% | 98.00% | -- | 100.00% | -46,328.57% |
| Cash from Financing | -97.58% | -78.60% | 520,758.54% | 101.63% | -1,234.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.98% | -67.44% | 175.76% | -1,039.06% | 102.06% |